ABBVIE INC. Share Price
NYSE: ABBV | Mega CapABBVIE INC. Stock Performance
ABBVIE INC. Share Price Today
As of 31 October 2026, ABBVIE INC.'s share price is $294.74. The stock opened at $293.41, compared to its previous close of $290.75. During today's trading session, ABBVIE INC.'s share price traded between $292.93 and $298.60, with an average price of $295.76. Over the past 52 weeks, the stock has recorded a high of $298.60 and a low of $191.33. In terms of performance, ABBVIE INC.'s share price has risen by 39.43% over the last six months and is up 35.14% on a year-on-year basis.
ABBVIE INC. Share Price Chart
ABBVIE INC. Quarterly Profit & Loss
All figures in USD
ABBVIE INC. Annual Profit & Loss
All figures in USD
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
ABBVIE INC. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $260.56 | $294.21 | +12.12% |
Sep 2026 | $260.84 | $262.40 | +1.65% |
Aug 2026 | $251.95 | $258.14 | +2.89% |
Jul 2026 | $250.81 | $250.88 | -0.17% |
Jun 2026 | $215.88 | $251.31 | +15.41% |
May 2026 | $209.44 | $217.76 | +3.02% |
Apr 2026 | $218.48 | $211.38 | -2.79% |
Mar 2026 | $234.18 | $217.46 | -6.36% |
Feb 2026 | $224.78 | $232.22 | +4.14% |
Jan 2026 | $228.21 | $223.00 | -2.40% |
Dec 2025 | $227.70 | $228.48 | +0.31% |
Nov 2025 | $217.10 | $227.77 | +4.43% |